Drug profile · INN
fosaprepitant dimeglumine
FOSAPREPITANT DIMEGLUMINE
fosaprepitant dimeglumine (FOSAPREPITANT DIMEGLUMINE) is a neurokinin 1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: unknown. Current US regulatory status: approved.
Drug details — fosaprepitant dimeglumine
- US status
- approved
- Class
- —
- Route
- UNKNOWN
- Patents
- 0
- Programs
- 4
- Data quality
- 0.89
Quick answer
fosaprepitant dimeglumine (FOSAPREPITANT DIMEGLUMINE) is a neurokinin 1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: unknown. Current US regulatory status: approved.
Key facts
Mechanism of action
Neurokinin 1 receptor antagonist
Primary target: Substance-P receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is fosaprepitant dimeglumine?
fosaprepitant dimeglumine (FOSAPREPITANT DIMEGLUMINE) is a neurokinin 1 receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: unknown. Current US regulatory status: approved.
What is the brand name for fosaprepitant dimeglumine?
FOSAPREPITANT DIMEGLUMINE is a marketed brand name for fosaprepitant dimeglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fosaprepitant dimeglumine?
fosaprepitant dimeglumine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.